ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

FRANCISCO C. PARRA, M.D. L.L.C.

CALLE MARGINAL B-16 URBANIZACION FLAMBOYAN

Manati | Puerto Rico | 00674

(305) 884-9062

Incorrect Info?
Search this name in Dollars for Docs »

At A Glance: This Prescriber in 2012

Ambulatory Health Care Facilities, Mental Health Including Community Mental Health Center

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,785Medicare Part D Prescriptions Filled, Including Refills
$341K Total Retail Price of All Prescriptions
660 Patients Receiving at Least One Drug in Part D
25%Patients 65 Years and Older
2% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
FLUOXETINE HCL 564 88
TRAZODONE HCL 537 195
SERTRALINE HCL 353 82
ZOLPIDEM TARTRATE 346 66
BUPROPION HCL SR 341 80
VENLAFAXINE HCL ER 315 62
BUPROPION XL 314 30
DOXEPIN HCL 286 21
GABAPENTIN 281 28
PAROXETINE HCL 273 80
CITALOPRAM HBR 262 107
MIRTAZAPINE 221 71
RISPERIDONE 198 30
DIVALPROEX SODIUM ER 193 24
CYMBALTA 142 19
QUETIAPINE FUMARATE 117 42
AMITRIPTYLINE HCL 111 0 R
SEROQUEL 108 36
BUSPIRONE HCL 107 14
SEROQUEL XR 102 0
NORTRIPTYLINE HCL 101 15
LITHIUM CARBONATE 99 0
BUDEPRION XL 95 14 10
HYDROXYZINE PAMOATE 90 0 R
ABILIFY 89 0
DIPHENHYDRAMINE HCL 64 0 R
BENZTROPINE MESYLATE 60 11 R
INVEGA SUSTENNA 52 19
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.